Table 1.
Characteristics of the registered primary liver cancer cases in Georgia, 2015-2022.
Fig 1.
Annual number of primary liver cancer (PLC) Cases in Georgia, 2015-2022.
Data from the Georgian Cancer Registry presented as a line graph, illustrating trends in registered adult PLC cases over the 8-year period.
Fig 2.
HCV Screening rate among primary liver cancer (PLC) cases in Georgia, 2015-2022.
The bar graph illustrates the annual percentage of newly diagnosed PLC patients screened at least once for anti-HCV, showing the increase in screening coverage over time.
Fig 3.
Timing of anti-HCV testing relative to primary liver cancer (PLC) diagnosis among registered PLC cases in Georgia, 2015-2022.
The bar graph illustrates the proportion of first recorded anti-HCV test results in relation to the date of PLC diagnoses, grouped in 6-month intervals.
Fig 4.
Care Cascade for Hepatitis C Testing and Treatment among PLC Cases in Georgia, 2015-2022.
The bar graph shows the cumulative absolute numbers and proportion of the PLC cases assessed and treated for HCV infection. SVR achievement was defined for only those who completed at least one round of treatment and was based on patients’ latest round of treatment.
Fig 5.
Timing of the HCV treatment initiation relative to primary liver cancer (PLC) diagnosis among registered PLC cases in Georgia, 2015-2022.
The bar graph illustrates the proportion of initiated earliest round of treatment in relation to the date of PLC diagnoses, grouped in 1-year intervals.